7.84
Neogenomics Inc 주식(NEO)의 최신 뉴스
NeoGenomics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo
How to Take Advantage of moves in (NEO) - news.stocktradersdaily.com
Press Release Distribution & PR Platform - ACCESS Newswire
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2025 Earnings Call Transcript - MSN
NeoGenomics (NEO) Price Target Lowered by Morgan Stanley | NEO S - GuruFocus
NeoGenomics (NEO) Price Target Lowered by Morgan Stanley | NEO Stock News - GuruFocus
NeoGenomics Repays $201.3 Million Convertible Senior Notes - marketscreener.com
NeoGenomics price target lowered to $10 from $17 at Morgan Stanley - Yahoo Finance
NeoGenomics clears $201.25M convertible debt ahead of maturity By Investing.com - Investing.com India
NeoGenomics clears $201.25M convertible debt ahead of maturity - Investing.com
NeoGenomics Pays Off 1.25% Convertible Senior Notes - Business Wire
NeoGenomics (NEO) Shares Drop After Disappointing Q1 Revenue Rep - GuruFocus
NeoGenomics targets 25% annual NGS growth with new product launches in 2025 - MSN
NeoGenomics (NEO) Stock Target Reduced by Morgan Stanley Amid Q1 - GuruFocus
Leerink Partners Downgrades NeoGenomics (BMV:NEO) - Nasdaq
NeoGenomics (NEO) Faces Price Target Cut Amid Significant Sellof - GuruFocus
NeoGenomics (NEO) Faces Price Target Reduction Amid Sales Challe - GuruFocus
NeoGenomics (NEO) Price Target Cut by BTIG Amid Revenue Concerns - GuruFocus
NeoGenomics stock hits 52-week low at $6.25 amid market challenges - Investing.com India
NeoGenomics Q1 Earnings: The Stock Price Drop Is A Gift (Rating Upgrade) (NEO) - Seeking Alpha
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform - BioSpace
NeoGenomics Reports Strong Q1 2025 Performance - TipRanks
NeoGenomics (NEO) Kicks Off 2025 with Strong Revenue Momentum | - GuruFocus
NeoGenomics: Q1 Earnings Snapshot - MySA
NeoGenomics Reports Strong Q1 2025 Earnings Growth - TipRanks
NeoGenomics Q1 2025 Earnings Call Transcript - MarketBeat
NeoGenomics (NEO) Downgraded Amid Growth Concerns | NEO Stock Ne - GuruFocus
Why NeoGenomics (NEO) Stock Is Nosediving - MSN
Health Care Stocks Rise As Pfizer And AstraZeneca Lead Gains - Finimize
Fort Myers-based NeoGenomics posts $26M net loss in Q1 - Gulfshore Business
Earnings call transcript: NeoGenomics Q1 2025 revenue misses forecast, stock drops - Investing.com
NeoGenomics drops as sequential revenue decline leads to Q1 miss - MSN
NeoGenomics stock drops on Q1 miss (NEO:NASDAQ) - Seeking Alpha
NeoGenomics Q1 2025 Financial Results: Sales Growth Amid Profitability ChallengesNews and Statistics - IndexBox
NeoGenomics Reports First Quarter 2025 Results - BioSpace
NeoGenomics and Ultima Genomics collaborate to expand clinical t - GuruFocus
NeoGenomics Inc (NEO) Q1 2025 Earnings: EPS of -$0.20 Beats Esti - GuruFocus
NeoGenomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
NeoGenomics falls after Q1 sales miss - TradingView
NEO Updates FY25 Guidance Following Pathline Acquisition | NEO S - GuruFocus
NeoGenomics (NEO) Reports Break-Even Earnings for Q1 - Yahoo Finance
NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops - Yahoo Finance
Earnings Flash (NEO) NEOGENOMICS INC. Reports Q1 Revenue $168M, vs. FactSet Est of $170.6M - marketscreener.com
Indo-Asian News Service - Indo-Asian News Service (IANS)
Insights Ahead: NeoGenomics's Quarterly Earnings - Benzinga
NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For - Yahoo
Bank of Montreal Can Lowers Position in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat
자본화:
|
볼륨(24시간):